Strategic Family Wealth Counselors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
+1,163
New +$200K 0.05% 164
2023
Q1
– Sell
-1,736
Closed -$228K – 108
2022
Q4
$228K Hold
1,736
– – 0.11% 94
2022
Q3
$203K Hold
1,736
– – 0.1% 87
2022
Q2
$204K Sell
1,736
-257
-13% -$30.5K 0.1% 91
2022
Q1
$260K Sell
1,993
-152
-7% -$19.8K 0.1% 83
2021
Q4
$327K Sell
2,145
-62
-3% -$9.6K 0.1% 75
2021
Q3
$357K Buy
2,207
+750
+51% +$126K 0.12% 64
2021
Q2
$238K Sell
1,457
-734
-34% -$113K 0.08% 76
2021
Q1
$330K Hold
2,191
– – 0.12% 61
2020
Q4
$332K Hold
2,191
– – 0.17% 63
2020
Q3
$297K Sell
2,191
-89
-4% -$12.1K 0.17% 61
2020
Q2
$312K Buy
2,280
+3
+0.1% +$382 0.2% 60
2020
Q1
$245K Sell
2,277
-332
-13% -$38.2K 0.18% 63
2019
Q4
$314K Sell
2,609
-134
-5% -$14.9K 0.25% 50
2019
Q3
$273K Sell
2,743
-237
-8% -$24.8K 0.21% 54
2019
Q2
$325K Buy
2,980
+70
+2% +$7.45K 0.25% 48
2019
Q1
$325K Hold
2,910
– – 0.26% 47
2018
Q4
$281K Buy
+2,910
New +$309K 0.32% 48

Other funds holding IBB

Strategic Family Wealth Counselors's IBB Position: Q2 2026 in Review

Strategic Family Wealth Counselors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,163 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #164 among its holdings. This is a return to the name: Strategic Family Wealth Counselors previously reported a position in IBB as recently as Q4 2022.

Strategic Family Wealth Counselors first reported a position in IBB in Q4 2018 and has held it in 18 quarters since. The position peaked at $357K in Q3 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Strategic Family Wealth Counselors held 1,163 shares of iShares Biotechnology ETF worth $221K as of Q2 2026.
  • iShares Biotechnology ETF was a new Strategic Family Wealth Counselors position in Q2 2026.
  • iShares Biotechnology ETF made up 0.05% of Strategic Family Wealth Counselors's portfolio in Q2 2026, its #164 holding.
  • Strategic Family Wealth Counselors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 18 quarters since.
  • Strategic Family Wealth Counselors's iShares Biotechnology ETF position peaked at $357K in Q3 2021.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Strategic Family Wealth Counselors's 13F filing for Q2 2026, filed 14 Aug 2026.